Continuous-flow left ventricular assist device and the right ventricle

AACN Advanced Critical Care

Volumn 23, Issue 1, 2012, Pages 86-90

  Puhlman, Mark ^a  

^a SACRED HEART MEDICAL CENTER   (United States)

Author keywords

heart failure; left ventricular assist device; LVAD; right ventricular failure

Indexed keywords

HEART ASSIST DEVICE; HEART FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; HUMAN; PATHOLOGY; POSTOPERATIVE CARE; REVIEW; RISK ASSESSMENT;

HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; POSTOPERATIVE CARE; RISK ASSESSMENT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84856907900     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0b013e31823ef240     Document Type: Article

References (17)

1. Rose E, Gelijins A, Moskowitz AJ, et al; REMATCH Study Group. Long term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20): 1435-1443.
2. Jessup M, Abraham WT Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977-2016.
3. United Network for Organ Sharing. UNOS 2009 SRTR Annual Report. Richmond, VA: United Network for Organ Sharing; 2010.
4. Miller L, Pagani F, Russell S, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-892.
5. Kirklin J, Naftel D, Kormos R, et al. Third annual report: The evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30(1):115-123.
6. Iribarne A, Pak S, Russo M, et al. Incremental cost of right ventricular failure after left ventricular assist device placement. J Am Coll Cardiol. 2011;57(17):313. doi:10.1016/S0735- 1097(11)60313-60316.
7. Barnes K. Complications in patients with ventricular assist devices. Dimens Crit Care Nurs. 2008;27(6):233-241.
8. Matthews J, Koelling T, Pagani F, Aaronson K. The right ventricular risk score. J Am Coll Cardiol. 2008;51:2163-2172.
9. Lund, L, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail. 2010;12:434-443.
10. Kormos RL, Teuleberg JJ, Paganni FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. J Thoracic Cardiovasc Surg. 2010;139(5):1316-1324.
11. Primacor [package insert]. Bridgewater, NJ: Sanofi Winthrop-US. Rev 7/92, Rec 2/93; Rev 4/96, Rec 7/97.
12. Craig ML. Management of right ventricular failure in the era of ventricular assist device. Curr Heart Failure Rep. 2011;8:65-71.
13. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1-S39.
14. Popepov EV, Steanenko A, Dandel M, et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant. 2008;27(12):1275-1281.
15. Patel N, Weiss E, Schaffer J, et al. Right heart dysfunction after left ventricular assist device implantation: A comparison of the Palatial HeartMate I and Axial-Flow HeartMate II devices. Ann Thoracic Surg. 2008;86:832-840.
16. Maeder M, Leet A, Ross A, et al. Changes in right ventricular function during continuous flow left ventricular assist device support. J Heart Lung Transplant. 2009;28: 360-366.
17. Slaughter M, Rogers J, Milano C, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.